The first human questions
Early clinical research · Published 2015–2018
Is it staying in the body—and how does it feel?
Subject One rolls up a sleeve and prepares an impressive speech about bravery. Nobody requests the speech. They want measurements, a schedule and an honest account of how he feels. He writes “less heroic than expected” in the margin.
What changes here
Early human research asked about exposure, tolerability and glucose control in different study populations. [2] [1]
Read the study details & dates
Testing the diabetes signal
A randomized 12-week trial enrolled 415 adults with type 2 diabetes. Glucose control, weight changes and tolerability helped guide the later Phase 3 program. [1]
Following the medicine through the body
A separate study in 44 healthy Japanese and Caucasian male volunteers investigated exposure, pharmacodynamics and tolerability. Healthy-volunteer findings answer different questions from a trial treating diabetes. [2]
What this does not establish
These are documented early clinical studies, not a verified first-ever human dose. Research streams overlap, and papers may be published years after a study takes place. The fictional scene combines no actual participant records.
Original sources
Sources reviewed 2026-10-11. Study and publication dates are stated separately where known.
Subject One is fictional. Separate studies, species and populations are not a single patient’s experience. How to read the story